PTCA薬剤コーティングバルーン（DCB）カテーテル市場：パイプラインレポート（開発段階、セグメント、地域・国、規制経路、主要企業）、2024年最新版

薬剤コーティングバルーン（DCB）カテーテルは、冠動脈の再狭窄を防ぐことを目的とした抗再狭窄薬剤コーティングPTCAバルーンカテーテルです。DCBカテーテルは迅速、短期間、均質、局所的な薬剤デリバリーを提供します。DCBカテーテルは血管の解剖学的構造を維持し、血管の治癒を促進し、金属を残すことなく長期の抗血小板二重療法の必要性を減少させます。

当レポートでは、PTCA薬剤コーティングバルーン（DCB）カテーテル市場について調査し、製品概要と開発中のパイプライン製品動向、様々な開発段階にある製品の比較分析や進行中の臨床試験に関する情報、参入企業の最近の動向などを提供しています。

目次

第1章 目次

第2章 イントロダクション

• PTCA薬剤コーティングバルーン（DCB）カテーテルの概要

第3章 開発中の製品

• PTCA薬剤コーティングバルーン（DCB）カテーテル - 開発段階別パイプライン製品
• PTCA薬剤コーティングバルーン（DCB）カテーテル - 地域別パイプライン製品
• PTCA薬剤コーティングバルーン（DCB）カテーテル - 規制経路別パイプライン製品
• PTCA薬剤コーティングバルーン（DCB）カテーテル - 推定承認日別パイプライン製品
• PTCA薬剤コーティングバルーン（DCB）カテーテル - 進行中の臨床試験

第4章 PTCA薬剤コーティングバルーン（DCB）カテーテル- 各社開発中のパイプライン製品

• PTCA薬剤コーティングバルーン（DCB）カテーテル企業- 開発段階別のパイプライン製品
• PTCA薬剤コーティングバルーン（DCB）カテーテル- 開発段階別のパイプライン製品

第5章 PTCA薬剤コーティングバルーン（DCB）カテーテルの企業と製品の概要

• Aachen Resonance GmbH
• Acotec Scientific Co Ltd
• Advanced NanoTherapies Inc
• B. Braun Interventional Systems Inc
• Boston Scientific Corp
• Caliber Therapeutics, Inc.
• Chansu Vascular Technologies LLC
• Concept Medical Inc
• Cordis US Corp
• Dongguan TT Medical Inc
• Innova Vascular Inc
• Jiwei Medical System Ltd
• Lepu Medical Technology（Beijing）Co Ltd
• Lifetech Scientific (Shenzhen) Co Ltd
• Medtronic Plc
• MicroPort Scientific Corp
• OrbusNeich
• Orchestra BioMed Inc
• QT Vascular Ltd
• Rontis Hellas SA
• Shanghai MicroPort Medical Group Co Ltd
• Shanghai XinZhi Medical Technology Co Ltd
• Shenzhen Salubris Pharmaceuticals Co Ltd
• Spectranetics Corp
• Vascular Nanotransfer Technologies

第6章 PTCA薬剤コーティングバルーン（DCB）カテーテル- 最近の開発

第7章 付録

• 調査手法
• GlobalDataについて
• お問い合わせ
• 免責事項

List of Tables

• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Stage of Development
• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Territory
• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Regulatory Path
• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Estimated Approval Date
• PTCA Drug Coated Balloon (DCB) Catheters - Ongoing Clinical Trials
• PTCA Drug Coated Balloon (DCB) Catheters Companies - Pipeline Products by Stage of Development
• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Stage of Development
• Glossary

List of Figures

• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Stage of Development
• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Territory
• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Regulatory Path
• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Estimated Approval Date
• PTCA Drug Coated Balloon (DCB) Catheters - Ongoing Clinical Trials

GlobalData's Medical Devices sector report, "PTCA Drug Coated Balloon (DCB) Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the PTCA Drug Coated Balloon (DCB) Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A Drug Coated Balloon (DCB) Catheter is an anti-restenotic drug coated PTCA balloon catheter intended to prevent re-narrowing of the coronary arteries. DCB Catheters provide fast, short-term, homogenous, local drug delivery. DCB catheters preserve the anatomy of the vessel, promote enhanced vessel healing, and reduce the need for prolonged dual anti-platelet therapy without leaving any metal behind.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the PTCA Drug Coated Balloon (DCB) Catheters under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of PTCA Drug Coated Balloon (DCB) Catheters and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of PTCA Drug Coated Balloon (DCB) Catheters under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 PTCA Drug Coated Balloon (DCB) Catheters Overview

3 Products under Development

• 3.1 PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Stage of Development
• 3.2 PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Territory
• 3.3 PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Regulatory Path
• 3.4 PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Estimated Approval Date
• 3.5 PTCA Drug Coated Balloon (DCB) Catheters - Ongoing Clinical Trials

4 PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products under Development by Companies

• 4.1 PTCA Drug Coated Balloon (DCB) Catheters Companies - Pipeline Products by Stage of Development
• 4.2 PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Stage of Development

5 PTCA Drug Coated Balloon (DCB) Catheters Companies and Product Overview

• 5.1 Aachen Resonance GmbH Company Overview
  • 5.1.1 Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Acotec Scientific Co Ltd Company Overview
  • 5.2.1 Acotec Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Advanced NanoTherapies Inc Company Overview
  • 5.3.1 Advanced NanoTherapies Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 B. Braun Interventional Systems Inc Company Overview
  • 5.4.1 B. Braun Interventional Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 Boston Scientific Corp Company Overview
  • 5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 Caliber Therapeutics, Inc. Company Overview
  • 5.6.1 Caliber Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Chansu Vascular Technologies LLC Company Overview
  • 5.7.1 Chansu Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 Concept Medical Inc Company Overview
  • 5.8.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Cordis US Corp Company Overview
  • 5.9.1 Cordis US Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 Dongguan TT Medical Inc Company Overview
  • 5.10.1 Dongguan TT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 Innova Vascular Inc Company Overview
  • 5.11.1 Innova Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 Jiwei Medical System Ltd Company Overview
  • 5.12.1 Jiwei Medical System Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 Lepu Medical Technology (Beijing) Co Ltd Company Overview
  • 5.13.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
  • 5.14.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 Medtronic Plc Company Overview
  • 5.15.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 MicroPort Scientific Corp Company Overview
  • 5.16.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 OrbusNeich Company Overview
  • 5.17.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 Orchestra BioMed Inc Company Overview
  • 5.18.1 Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 QT Vascular Ltd Company Overview
  • 5.19.1 QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.20 Rontis Hellas SA Company Overview
  • 5.20.1 Rontis Hellas SA Pipeline Products & Ongoing Clinical Trials Overview
• 5.21 Shanghai MicroPort Medical Group Co Ltd Company Overview
  • 5.21.1 Shanghai MicroPort Medical Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.22 Shanghai XinZhi Medical Technology Co Ltd Company Overview
  • 5.22.1 Shanghai XinZhi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.23 Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview
  • 5.23.1 Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.24 Spectranetics Corp Company Overview
  • 5.24.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.25 Vascular Nanotransfer Technologies Company Overview
  • 5.25.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview

6 PTCA Drug Coated Balloon (DCB) Catheters- Recent Developments

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer